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Psi-tectorigenin, an isoflavonoid, was isolated from a culture filtrate of actinomycetes as an inhibitor of epidermal growth 
factor-induced phosphatidylinositol turnover in cultured A431 cells. It inhibited phosphatidylinositol turnover with an 
IC,, of about 1 pg/ml; thus, its inhibitory activity was 6-times stronger than that of genistein or orobol. When added 
to cultured A43 I cells psi-tectorigenin i hibited phosphatidylinositol turnover without inhibiting epidermal growth factor 
receptor tyrosine protein kinase. Thus, psi-tectorigenin is a specific inhibitor of phosphatidylinositol turnover and may 
be a useful tool for the functional analysis of phosphatidylinositol turnover. 
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1. INTRODUCTION 
We have previously isolated erbstatin from a 
Sfreptomyces culture filtrate as an inhibitor of 
tyrosine-specific protein kinase [I]. It inhibited 
epidermal growth factor (EGF)-induced auto- 
phosphorylation of EGF receptor and autophos- 
phorylation of the pp60src protein. However, it did 
not inhibit EGF-induced phosphatidylinositol 
(PtdIns) turnover in cultured A431 cells [2]. 
Increased turnover of PtdIns and of its 
phosphorylated derivatives, phosphatidylinositol 
4-phosphate (PtdIns-P) and 4,5bisphosphate 
(PtdIns-Pz), has been implicated in the cellular 
response to growth factors such as EGF [3], 
platelet-derived growth factor [4], or interleukin-2 
151. PtdIns-Pz breakdown generates two second 
messengers, diacylglycerol and inositol trisphos- 
phate. Diacylglycerol activates protein kinase C 
[6], and inositol trisphosphate mobilizes calcium 
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from an internal source 171. Furthermore, several 
studies have shown that levels of inositol trisphos- 
phate and diacylglycerol are elevated in a variety of 
transformed cell lines [g-lo]. Taken together, 
these reports led to the speculation that viral 
transformation might be initiated through an in- 
crease in phosphorylation of PtdIns resulting in an 
increase in the supply of inositol trisphosphate and 
diacylglycerol which then would act as second 
messengers to stimulate cell growth. 
Therefore, we have screened culture filtrates of 
microorganisms for an inhibitor of PtdIns tur- 
nover and isolated psi-tectorigenin. 
2. MATERIALS AND METHODS 
2.1. Materials 
EGF was purchased from Takara Shuzo. [‘H]Inositol 
(14.0 Ci/mmol) and [“P]orthophosphate (32Pi) (1 mCi/ml) 
were obtained from Dupon, while [y-=P]ATP 
(10.54 Ci/mmoI) was from New England Nuclear. The syn- 
thetic peptide RR-SRC was purchased from the Peptide In- 
stitute (Osaka). The A431 cell line was obtained from Dr S. 
Kawai (Institute of Medical Science, University of Tokyo). 
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2.2. Isolation of psi-tectorigenin 
The actinomycetes train SA1715 was cultured in a 500 ml 
Erlenmeyer flask containing 110 ml of medium consisting of 
2% glucose, 2070 soybean meal and 0.1% CaC03 (pH 7.6) on a 
rotary shaker at 27°C for 48 h; 3.0 ml of the cultured broth was 
then inoculated into a 500 ml flask containing 110 ml of the 
above medium. The fermentation was carried out at 27°C for 
4 days. The broth filtrate was extracted with butyl acetate and 
the extract concentrated in vacua. The dried material was 
dissolved in CHCls and applied onto a silica gel column. After 
washing with CHCI,, the active fraction was eluted with 
CHClj-MeOH (100: I). The eluate was dried and then dissolved 
in a small amount of methanol for separation by Toyopearl 
HW-40 column chromatography. The active component was 
further purified by reverse-phase high-performance liquid 
chromatography using 60% acetonitrile as an eluent. 
2.3. Phosphatidylinositol turnover assay 
A431 cells (3 x 105) grown for 16 h beforehand were prein- 
cubated in 1 ml Hepes-buffered saline (HBS) (20 mM Hepes, 
150 mM NaCl, 5 mM KCl, 1 mM CaC12, 1 mM MgClz, 0.1% 
glycerol) containing [3H]inositol (1 &i/ml) at 37°C for 30 min. 
Then, a test chemical and EGF (400 ng/ml) were added, and the 
incubation was continued at 37°C for 60 min. Subsequently, 
0.5 ml of 10% trichloroacetic acid containing 0.01 M sodium 
pyrophosphate was added, and the acid-insoluble fraction was 
scraped off from the dish in 1.0 ml H20. The lipid was ex- 
tracted from it by the addition of CHCl3 and CHXOH (1: 1) and 
[3H]inositol-labeled lipids counted by liquid scintillation spec- 
trophotometry. 
32PL incorporation into phospholipids was assayed as follows. 
A431 cells (5 x 10’ cells) were plated in 35-mm dishes I6 h 
before use and washed with HBS. The cells were incubated in 
1 .O ml HBS containing 20 pCi “Pi with psi-tectorigenin and/or 
EGF at 37°C for 30 min, after which 0.5 ml of 10% 
trichloroacetic acid was added. The cells were scraped off and 
the lipids extracted with CHCl, and MeOH. Lipid extracts 
labeled with “Pi were concentrated and spotted on a silica gel 
F thin-layer chromatography plate. The plate was developed 
with chloroform-methanol-acetic acid-H20 (25: 15:4:2). 
Radioactive spots were identified by autoradiography. 
2.4. Tyrosine protein kinase assay [ll] 
The reaction mixture containing 1 mg/ml of a synthetic pep- 
tide (RR-SRC), 8.3 &i/ml of (y-“P]ATP, 50 ng/ml of EGF 
and the membrane fraction of A431 cells with or without in- 
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Fig. 1. Structure of isoflavonoids. 
hibitor was incubated at 0°C for 30 min in 6081 of 10 mM 
Hepes buffer (pH 7.2). The reaction was then stopped by the 
addition of 25 ~1 of 10% trichloroacetic acid and 6 pl bovine 
serum albumin at 10 mg/ml. After incubation at 0°C for 
30 min, the mixture was centrifuged (13000 rpm, 5 min). 
Thereafter, 45 pl of the supernatant was applied to a 1.5 x 
1.5 cm piece of P81 phosphocellulose paper. The paper was 
then washed in 30010 acetic acid for 15 min, 3 times in 15% 
acetic acid at room temperature, and finally rinsed in acetone. 
It was dried and counted for radioactivity. 
In situ inhibitory activity of psi-tectorigenin against tyrosine 
kinase was examined as follows: A431 cells (5 x 105) were 
grown in 35-mm dishes for 18 h before use. The cells were 
washed twice with phosphate-free Dulbecco’s modified Eagle 
medium (DMEM) supplemented with 4% dialyzed serum and 
then labeled for 4 h with 150&i “Pi in 1 ml phosphate-free 
medium. Then, psi-tectorigenin and/or EGF were added. After 
30 min, cells were extracted with 0.5 ml Radio-immune 
precipitation (RIPA) buffer. The clarified cell extract (100 ~1) 
was incubated for 2 h at 0°C with a saturating amount (IO ~1) 
of monoclonal anti-EGF receptor antibody and then 200 pl of 
a suspension of Staphylococcus aureus Cowan I was added, and 
the mixture allowed to stand at 4’C overnight. The bacterial 
cells adsorbing the immune complexes were then washed with 
RIPA buffer 5 times at 4”C, suspended in 50 ,~l electrophoresis 
loading buffer, boiled for 5 min, and centrifuged at 15000 x g 
for 1 min. The supernatant was electrophoresed on an SDS- 
polyacrylamide gel, after which the gel was stained with 
Coomassie blue, dried, and autoradiographed. 
3. RESULTS 
A culture filtrate from an actinomycetes train 
found in a river near Shanghai showed strong in- 
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Fig.2. Inhibition of phosphatidylinositol turnover by psi- 
tectorigenin and other isoflavonoids. Psi-tectorigenin (0), 
orobol (0) or genistein (A) was added to cultured A431 cells 
preincubated with labeled inositol for 60 min with EGF. The 
lipid fraction was extracted and counted. Control value was 
9245 cpm. 
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Table 1 
Effect of psi-tectorigenin on EGF-induced phosphatidylinositol 
turnover 
‘*Pi incorporation’ 
cpm(%) 
PI PA 
None 224 1161 
EGF 4704 6779 
+ 5 pg/ml psi-tectorigenin 764 1666 
+ 10 281 1651 
+ 50 510 1984 
a A431 cells were incubated with psi-tectorigenin and labeled 
sodium phosphate for 30 min 
PI, phosphatidylinositol; PA, phosphatidic acid 
hibition against PtdIns turnover. The active princi- 
ple was purified and its structure was found to be 
identical with that of psi-tectorigenin by NMR 
(fig. 1). 
As shown in fig.2, psi-tectorigenin inhibited 
EGF-induced inositol incorporation with an I& 
of about 1 pg/ml in our assay system. The in- 
hibitory activity of psi-tectorigenin was several 
times stronger than that of orobol or genistein. 
Inhibition of PtdIns turnover by psi-tectorigenin 
“J! 
0.04 0.15 0.6 2.5 10 
p/ml 
Fig.3. Inhibition of EGF receptor tyrosine kinase by 
isoflavonoids. The reaction mixture containing psi-tectorigenin 
(o), orobol (0) or genistein (A) with A431 cell membranes, 
peptide substrate and y-labeled ATP was incubated for 30 min 
at 0°C. The labeled peptide was collected on phosphocellulose 
paper and its radioactivity counted. Control value was 
2331 cpm. 
Fig.4. Effect of psi-tectorigenin on EGF receptor tyrosine 
kinase. Cultured A431 cells were supplemented with psi- 
tectorigenin for 30 min. The labeled EGF receptor (170 kDa) 
was precipitated and subjected to SDS gel electrophoresis. 
was further confirmed by Pi incorporation into 
phospholipids. Incorporation of Pi into both 
phosphatidic acid and phosphatidylinositol was 
markedly enhanced by EGF in A431 cells, and ad- 
dition of 5-50 pg/ml of psi-tectorigenin inhibited 
formation of phosphatidic acid by about 90% and 
that of PtdIns by 90-99%, as shown in table 1. 
Psi-tectorigenin, orobol, and genistein all show- 
ed similar in vitro inhibitory activity against EGF 
receptor tyrosine protein kinase, with an I& of 
about 0.1 /g/ml as shown in fig.3. However, psi- 
tectorigenin did not inhibit EGF receptor tyrosine 
kinase at 50,ug/ml in situ, as shown in fig.4. 
4. DISCUSSION 
Psi-tectorigenin was first described in 1953 by 
Baker et al. [12] as a synthetic isomer of tec- 
torigenin. Later it was isolated from a culture 
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broth of Aspergillus niger NRRL3122 as a weak 
inhibitor of dopa decarboxylase [13]. Recently, 
orobol [l] and genistein [14], which have a struc- 
ture related to that of psi-tectorigenin, have been 
isolated from Streptomyces as inhibitors of 
tyrosine kinase. Genistein was also reported by 
Akiyama et al. [15] to inhibit EGF-induced PtdIns 
turnover. We found that orobol also inhibited 
PtdIns turnover with a similar I& value. 
However, the ICSO of psi-tectorigenin for PtdIns 
turnover was several times lower than those of 
genistein and orobol. 
Genistein was reported to inhibit both PtdIns 
turnover and EGF receptor tyrosine kinase at 
40-lOO,~g/ml in cultured A431 cells [15,16]. On 
the other hand, an immunoprecipitation experi- 
ment showed that psi-tectorigenin at 5-50 ,ug/ml 
did not markedly inhibit EGF receptor tyrosine 
protein kinase in cultured A431 cells, but only 
PtdIns turnover. In situ inhibition of tyrosine pro- 
tein kinase requires a higher concentration of the 
inhibitor than in vitro possibly due to slow 
penetration. Therefore, psi-tectorigenin is a more 
potent and specific inhibitor of PtdIns turnover 
than is genistein. 
Since no potent inhibitors of PtdIns turnover 
have been previously reported, psi-tectorigenin 
should prove to be a useful tool in functional 
studies of PtdIns turnover. 
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